Literature DB >> 24081608

Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3β.

Luisa Quesada-Romero1, Julio Caballero.   

Abstract

The binding modes of 42 oxadiazole derivates inside glycogen synthase kinase 3 beta (GSK3β were determined using docking experiments; thus, the preferred active conformations of these inhibitors are proposed. We found that these compounds adopt a scorpion-shaped conformation and they accept a hydrogen bond (HB) from the residue Val135 of the GSK3β ATP-binding site hinge region. In addition, quantitative structure-activity relationship (QSAR) models were constructed to explain the trend of the GSK3β inhibitory activities for the studied compounds. In a first approach, three-dimensional (3D) vectors were calculated using docking conformations and, by using multiple-linear regression, we assessed that GETAWAY vectors were able to describe the reported biological activities. In other QSAR approach, SMILES-based optimal descriptors were calculated. The best model included three-SMILES elements SSSβ leading to the identification of key molecular features that contribute to a high GSK3β inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081608     DOI: 10.1007/s11030-013-9483-5

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  25 in total

1.  Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations.

Authors:  Camila Muñoz; Francisco Adasme; Jans H Alzate-Morales; Ariela Vergara-Jaque; Torsten Kniess; Julio Caballero
Journal:  J Mol Graph Model       Date:  2011-10-20       Impact factor: 2.518

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.

Authors:  Fabio Lo Monte; Thomas Kramer; Jiamin Gu; Upendra Rao Anumala; Luciana Marinelli; Valeria La Pietra; Ettore Novellino; Bénédicte Franco; David Demedts; Fred Van Leuven; Ana Fuertes; Juan Manuel Dominguez; Batya Plotkin; Hagit Eldar-Finkelman; Boris Schmidt
Journal:  J Med Chem       Date:  2012-05-01       Impact factor: 7.446

4.  Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.

Authors:  Julio Caballero; Jans H Alzate-Morales; Ariela Vergara-Jaque
Journal:  J Chem Inf Model       Date:  2011-10-31       Impact factor: 4.956

Review 5.  Substrate competitive GSK-3 inhibitors - strategy and implications.

Authors:  Hagit Eldar-Finkelman; Avital Licht-Murava; Shmuel Pietrokovski; Miriam Eisenstein
Journal:  Biochim Biophys Acta       Date:  2009-09-18

Review 6.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

7.  CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats.

Authors:  A P Toropova; A A Toropov; E Benfenati; G Gini; D Leszczynska; J Leszczynski
Journal:  J Comput Chem       Date:  2011-06-08       Impact factor: 3.376

8.  QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.

Authors:  Partha Pratim Roy; Kunal Roy
Journal:  Chem Biol Drug Des       Date:  2009-04       Impact factor: 2.817

9.  Synthesis, in silico, in vitro, and in vivo investigation of 5-[¹¹C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2.

Authors:  Julio Caballero; Camila Muñoz; Jans H Alzate-Morales; Susana Cunha; Lurdes Gano; Ralf Bergmann; Joerg Steinbach; Torsten Kniess
Journal:  Eur J Med Chem       Date:  2012-10-23       Impact factor: 6.514

10.  The Blue Obelisk-interoperability in chemical informatics.

Authors:  Rajarshi Guha; Michael T Howard; Geoffrey R Hutchison; Peter Murray-Rust; Henry Rzepa; Christoph Steinbeck; Jörg Wegner; Egon L Willighagen
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

View more
  6 in total

1.  Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.

Authors:  Julio Caballero; Alejandro Morales-Bayuelo; Carlos Navarro-Retamal
Journal:  J Comput Aided Mol Des       Date:  2018-10-26       Impact factor: 3.686

2.  Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?

Authors:  David Ramírez; Julio Caballero
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

3.  Structural Requirements of N-alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Pseudomonas Aeruginosa Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies.

Authors:  José Luis Velázquez-Libera; Juliana Andrea Murillo-López; Alexander F de la Torre; Julio Caballero
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

4.  Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship.

Authors:  Carlos Navarro-Retamal; Julio Caballero
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

5.  Design, synthesis, structure, in vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3β of new indirubin-3'-oxime derivatives.

Authors:  Nguyen Trong Dan; Hoang Duc Quang; Vuong Van Truong; Do Huu Nghi; Nguyen Manh Cuong; To Dao Cuong; Tran Quoc Toan; Long Giang Bach; Nguyen Huu Thuan Anh; Nguyen Thi Mai; Ngo Thi Lan; Luu Van Chinh; Pham Minh Quan
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

6.  Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint Studies.

Authors:  José Luis Velázquez-Libera; Carlos Navarro-Retamal; Julio Caballero
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.